erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Tuberculosis D014376 20 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Otitis Media D010033 12 associated lipids
Adenocarcinoma D000230 166 associated lipids
Bacterial Infections D001424 21 associated lipids
Otitis Externa D010032 8 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Stomach Diseases D013272 7 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Skin Neoplasms D012878 12 associated lipids
Pleurisy D010998 20 associated lipids
Inflammation D007249 119 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Genital Diseases, Male D005832 3 associated lipids
Sexually Transmitted Diseases D012749 4 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Bone Resorption D001862 7 associated lipids
Arthritis D001168 41 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Abscess D000038 13 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Heart Failure D006333 36 associated lipids
Osteitis D010000 10 associated lipids
Osteomyelitis D010019 10 associated lipids
Liver Diseases D008107 31 associated lipids
Corneal Diseases D003316 13 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Hypersensitivity D006967 22 associated lipids
Acne Vulgaris D000152 35 associated lipids
Osteolysis D010014 8 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Lapchinskaia AV et al. [Changes in the microflora of the large intestine in rats administered cephalexin and erythromycin orally]. 1987 Antibiot. Med. Biotekhnol. pmid:3579249
Katrush VR and Zhukovskaia SA [Separation of emulsions during extraction of antibiotics from native solutions]. 1987 Antibiot. Med. Biotekhnol. pmid:3606053
Tsirkin RS [Antibiotic sensitivity of staphylococci associated with adenoviruses]. 1985 Antibiot. Med. Biotekhnol. pmid:3923916
Kuznetsov LE [Effect of a temperature regimen on erythromycin biosynthesis]. 1985 Antibiot. Med. Biotekhnol. pmid:4051468
Efimova OG et al. [Electron microscopic study of the interaction of cultures of Bordetella pertussis altered by antibiotic action with a human amniotic cell culture]. 1986 Antibiot. Med. Biotekhnol. pmid:2878640
Bukharovich AM and Kuz'menko VA [Effectiveness of complex therapy using ericyclin in patients with chronic pyoderma (5-year catamnestic data)]. 1986 Antibiot. Med. Biotekhnol. pmid:3767332
Zurabyan VA et al. [In vitro influence of biologically active factors of microorganisms on antibiotic susceptibility of Yersinia pestis]. 1997 Antibiot. Khimioter. pmid:9463297
Sadovnikova SF and Selina EV [Five years of sumamed on Russian market]. 1997 Antibiot. Khimioter. pmid:9463300
Ukhabotina LS et al. [Cloning of clusters of erythromycin biosynthesis genes of Streptomyces erythraeus (Saccharopolyspora erythraea)]. 1990 Antibiot. Khimioter. pmid:2150305
Sytnik SI [Antibiotic sensitivity of Staphylococci populating the breast skin of nursing women]. 1989 Antibiot. Khimioter. pmid:2730223
Bulgakova VG et al. [Metabolism of alpha-ketoacids in erythromycin biosynthesis in various strains of Saccharopolyspora erythraea]. 1993 Antibiot. Khimioter. pmid:8166559
Kirichenko VN et al. [Use of protoplast fusion in the selection of erythromycin-producing strains of Saccharopolyspora erythraea]. 1993 Antibiot. Khimioter. pmid:8166562
Strachynskił LS et al. [Pharmacoepidemiology of antibiotics in the treatment of respiratory tract infections in pediatric outpatients]. 1997 Antibiot. Khimioter. pmid:9412396
Nastasyak IN [Localization of rifampicin resistance determinants on genetic map of Saccharopolyspora erythraea]. 1997 Antibiot. Khimioter. pmid:9412406
Zavorotnaia SA et al. [Genetic instability of the feature of streptomycin resistance in Streptomyces erythraeus]. 1990 Antibiot. Khimioter. pmid:2078071
StrachunskiÄ­ LS et al. [Comparative clinical effectiveness and tolerance of azithromycin (sumamed) and erythromycin in patients with sinusitis]. 1993 Antibiot. Khimioter. pmid:8060176
Shubin SV et al. [Effectiveness of azithromycin relative to chlamydia infection in reactive arthritis]. 1993 Antibiot. Khimioter. pmid:8060177
Kirichenko NV et al. [Isolation and characterization of genetic recombinants in protoplast fusion in Saccharopolyspora erythraea]. 1993 Antibiot. Khimioter. pmid:8060179
Fomina IP et al. [Azithromycin (sumamed)--in the treatment of respiratory tract infections]. 1996 Antibiot. Khimioter. pmid:8929121
Ukhabotina LS et al. [Identification and characteristics of plasmids of the strains of erythromycin-producing Streptomyces erythreus]. 1988 Antibiot. Khimioter. pmid:2837155
Sazykin IuO [Modern macrolides and azalides in the therapy of infectious-inflammatory diseases. A seminar, February 1994, Moscow]. 1994 Feb-Mar Antibiot. Khimioter. pmid:7979801
Lialikov SA et al. [Monitoring of side effects and estimation of cycloferon efficacy in treatment of children with frequent and prolonged diseases]. 2012 Antibiot. Khimioter. pmid:23700934
Kolpakov AI et al. [Use of exogenous ribonuclease for improvement of Lactobacillus biological properties]. 1998 Antibiot. Khimioter. pmid:9791680
Platonova MM et al. [Clinical significance of fungal and microbial associations and antibacterial therapy for treatment of chronic inflammatory respiratory tract diseases in children]. 1998 Antibiot. Khimioter. pmid:9791682
Oriabinskaia LB et al. [Energy metabolism in Staphylococci containing plasmids of resistance to a number of antibiotics]. 1992 Antibiot. Khimioter. pmid:1296533
Grigor'ev AE et al. [Construction of hybrid plasmids containing genes for erythromycin biosynthesis and amplifying sequence AUD-Sr1 of Streptomyces rimosus]. 1992 Antibiot. Khimioter. pmid:1296539
Kurmanova KB et al. [Efficacy of pefloxacin in the treatment of complicated relapsing erysipelas]. 1997 Antibiot. Khimioter. pmid:9480650
Gagaeva EV and Firsov AA [Pharmacokinetics of protegentin, a combined preparation]. 1991 Antibiot. Khimioter. pmid:1953168
Arzumanian OG et al. [Effect of partial pressure of solute oxygen on the intensity of respiration of cultures of antibiotic producers]. 1990 Antibiot. Khimioter. pmid:2334239
Zakharova GM et al. [Study of the effect of protoplast formation on the antibiotic activity of erythromycin producers]. 1990 Antibiot. Khimioter. pmid:2334241
Grudinina SA et al. [Dynamics of Streptococcos pneumoniae antibiotic resistance extension in Moscow in 1998-2003]. 2004 Antibiot. Khimioter. pmid:15460020
Navashin SM and Nikitin AV [New macrolide antibiotics, rifamycins and peptide antibiotics discussed at the 27th International Conference on Antimicrobial Agents and Chemotherapy]. 1991 Antibiot. Khimioter. pmid:1850977
Nazarov AD et al. [Erythromycin pharmacokinetics in children after rectal and oral administration]. 1991 Antibiot. Khimioter. pmid:2025118
Korenev SV et al. [Pharmacological availability of erythromycin granules for children's use]. 1990 Antibiot. Khimioter. pmid:2264745
Bryzgalova TE et al. [Conditions for immobilizing Streptomyces erythreus in a calcium alginate gel and the apparatus setup for the process]. 1988 Antibiot. Khimioter. pmid:3288145
Vasilos LV et al. [Chemotherapeutic effectiveness of erythromycin, rifampicin and tetracyclines in chlamydiosis and mycoplasmosis in children]. 1995 Antibiot. Khimioter. pmid:8593094
BureÄ­ko SF et al. [Various properties of erythromycin basicity]. 1992 Antibiot. Khimioter. pmid:1514846
Dolgova GV et al. [Experimental study of a novel formulation for local application based on gentamicin, erythromycin and protease C]. 1990 Antibiot. Khimioter. pmid:2275587
Nigmatulin AZ et al. [Antibiotic binding by leukocytes from brucellosis patients]. 1990 Antibiot. Khimioter. pmid:2275592
Kotova NV [Kinetic and equilibrium parameters of erythromycin sorption on various sorbents]. 2009 Antibiot. Khimioter. pmid:20583559
Belousov IuB et al. [Dirithromycin in the treatment of infections of the lower respiratory tract]. 1995 Antibiot. Khimioter. pmid:8645058
Minaeva NZ et al. [Bacteria of the genus Arcobacter, a new etiological factor of nosocomial infections]. 2006 Antibiot. Khimioter. pmid:16878388
Gurevich KG et al. [Comparative pharmacokinetics of erythromycin target cell-associated transport and intravenous administration in patients with pneumonia]. 2006 Antibiot. Khimioter. pmid:18030786
Motina GL et al. [Effect of the methods of sterilization on the quality of nutrient media and on the level of antibiotic production]. 1991 Antibiot. Khimioter. pmid:1814272
Michurina TA et al. [Antioxidant effect on the growth of Saccharopolyspora erythraea and biosynthesis of erythromycins]. 2005 Antibiot. Khimioter. pmid:19140479
Petrova MS et al. [Antibiotic therapy in children with pertussis]. 1992 Antibiot. Khimioter. pmid:1300936
Berezhinskaia VV and Dolgova GV [Macrolide antibiotics and their use in combined pharmacotherapy]. 1989 Antibiot. Khimioter. pmid:2686571
Sereda EV et al. [Use of oral macrolide and azalide antibiotics in children with bronchopulmonary diseases]. 1994 Antibiot. Khimioter. pmid:7840711
Sazykin IuO et al. [Ketolides--erythromycin derivatives with activity against macrolide-resistant bacteria]. 2000 Antibiot. Khimioter. pmid:10707799
MashkilleÄ­son AL [Azithromycin in the treatment of syphilis]. 1994 Antibiot. Khimioter. pmid:7848005
Guchev IA et al. [Efficacy and safety of azithromycin prophylaxis of respiratory tract infections in military community]. 2004 Antibiot. Khimioter. pmid:15727144
Fomina IP [Second international conference on macrolides, azalides and streptogramins (Venice, Italy, January 19-22, 1994)]. 1994 Antibiot. Khimioter. pmid:7914722
Pozdniakova VP et al. [Protegentin--a combined preparation for the local treatment of suppurative infection]. 1993 Oct-Nov Antibiot. Khimioter. pmid:8085892
WILLIAMSON GM and ZINNEMANN K The susceptibility of coliform bacilli to erythromycin. 1962 Antibiot Chemother (Northfield) pmid:14007243
KIRBY WM et al. Erythromycin serum concentrations following administration in acid-resistant tablets. 1953 Antibiot Chemother (Northfield) pmid:24542409
KIRSHBAUM A et al. A cupplate method for the determination of erythromycin concentrations in serum and other body fluids. 1953 Antibiot Chemother (Northfield) pmid:24542421
CLARK RK The chemistry of erythromycin. I. Acid degradation products. 1953 Antibiot Chemother (Northfield) pmid:24542535
MAPLE FM et al. Serum concentrations of erythromycin following intravenous administration. 1953 Antibiot Chemother (Northfield) pmid:24542586
LEE CC et al. Tissue distribution of erythromycin in rats. 1953 Antibiot Chemother (Northfield) pmid:24542649
SYLVESTER JC and JOSSELYN LE Absorption of erythromycin. II. Erythromycin stearate. 1953 Antibiot Chemother (Northfield) pmid:24542651
GRIGSBY ME et al. Some laboratory and clinical experiences with erythromycin. 1953 Antibiot Chemother (Northfield) pmid:24542704
HASBROUCK RB and GARVEN FC The chemistry of erythromycin. II. Acid degradation products. 1953 Antibiot Chemother (Northfield) pmid:24542706
ANDERSON EA Cure of resistant meningococcemia with erythromycin. 1953 Antibiot Chemother (Northfield) pmid:24542853
HAIGHT TH et al. Erythromycin therapy of respiratory infections. II. Effects of varying durations of therapy of streptococcal infections on eradication of streptococci and on formation of antistreptolysin O. 1954 Antibiot Chemother (Northfield) pmid:24543018
LAING CR and SCOTT RB Erythromycin-polymyxin ointment in the treatment of pyoderma in children. 1954 Antibiot Chemother (Northfield) pmid:24543095
TUNEVALL G and HEDENIUS P Laboratory and clinical studies with erythromycin. 1954 Antibiot Chemother (Northfield) pmid:24543103
LEE CC et al. Site of absorption of erythromycin in rats. 1954 Antibiot Chemother (Northfield) pmid:24543219
MANTEN A Synergism and antagonism between antibiotic mixtures containing erythromycin. 1954 Antibiot Chemother (Northfield) pmid:24543317
KUZEL NR et al. Spectrophotometric determination of erythromycin in pharmaceutical products. 1954 Antibiot Chemother (Northfield) pmid:24543318
CLARK RK and TATERKA M The chemistry of erythromycin. III. Acid degradation products of erythromycin B. 1955 Antibiot Chemother (Northfield) pmid:24543468
CLARK RK and FREIFELDER M The synthesis of new erythromycins. 1957 Antibiot Chemother (Northfield) pmid:24544531
LEE CC et al. Further pharmacological studies on propionyl erythromycin ester lauryl sulfate. 1961 Antibiot Chemother (Northfield) pmid:13760219
CLARK RK and VARNER EL New esters of erythromycin. 1957 Antibiot Chemother (Northfield) pmid:24544532
MANIAR AC et al. A comparison of the in vitro and in vivo activity of erythromycin and spiramycin. 1960 Antibiot Chemother (Northfield) pmid:13766168
ROBINSON MM Demonstration by "challenge" of hepatic dysfunction associated with propionyl erythromycin ester lauryl sulfate. 1962 Antibiot Chemother (Northfield) pmid:14492925
GRIFFITH RS and BLACK HR A comparison of blood levels after oral administration of erythromycin and erythromycin estolate. 1962 Antibiot Chemother (Northfield) pmid:13901859
GRIFFITH RS and BLACK HR Comparison of antimicrobial activity of erythromycin estolate and demethylchlortetracycline against hemolytic streptococci. 1962 Antibiot Chemother (Northfield) pmid:13901860
GRIFFITH RS The ratio of antimicrobial activity between propionyl erythromycin lauryl sulfate and erythromycin ethyl carbonate. 1961 Antibiot Chemother (Northfield) pmid:13901862
GROGAN JB et al. Antibiotic susceptibility of phage type 80/81 strains of staphylococci isolated from hospital and community populations. 1962 Antibiot Chemother (Northfield) pmid:13902091
CORDERO FA Propionyl erythromycin ester lauryl sulfate in the treatment of treponematosis and chancroid. 1961 Antibiot Chemother (Northfield) pmid:13881298
STROM J Penicillin and erythromycin singly and in combination in scarlatina therapy and the interference between them. 1961 Antibiot Chemother (Northfield) pmid:13917845
LIMSON BM Lauryl sulfate salt of propionyl erythromycin: antibacterial activity in serum and therapeutic evaluation of low doses. 1961 Antibiot Chemother (Northfield) pmid:14465340
SALDANA TATE L In vivo and in vitro evaluation of oleandomycin, erythromycin, and tetracycline against cultures of Staphylococcus aureus. 1960 Antibiot Chemother (Northfield) pmid:14440930
SCHNEIERSON SS et al. Inhibition of Pseudomonas aeruginosa pigment formation by chloramphenicol and erythromycin. 1960 Antibiot Chemother (Northfield) pmid:14443279
Schmid EE The macrolide group of antibiotics. Mode of action. 1971 Antibiot Chemother (1971) pmid:4951002
Connamacher RH Inducible bacterial resistance. 1975 Antibiot Chemother (1971) pmid:773276
Wilson JT and van Boxtel CJ Pharmacokinetics of Erythromycin in man. 1978 Antibiot Chemother (1971) pmid:27136
Tanimoto H A review of the recent progress in treatment of patients with diffuse panbronchiolitis associated with Pseudomonas aeruginosa infection in Japan. 1991 Antibiot Chemother (1971) pmid:1801651
FORFAR JO and MACCABE AF Erythromycin--a review. 1957 Antibiot Chemother pmid:13488431
Siegenthaler W et al. [New antibiotics, with the exception of penicillins, streptomycin, tetracyclines and chloramphenicol]. 1968 Antibiot Chemother pmid:4302993
BATTERMAN RC et al. Responsiveness of commonly encountered respiratory infections to oral administration of erythromycin. 1956-1957 Antibiot Annu pmid:13425370
LOPEZ-BELIO M et al. Erythromycin in the bronchial tree after oral, intravenous, and aerosol administration. 1956-1957 Antibiot Annu pmid:13425371
MOURATOFF G et al. The effectiveness of erythromycin for the treatment of chronic genitourinary infections. 1956-1957 Antibiot Annu pmid:13425372
JOHNSON SA et al. Clinical observations on the use of erythromycin in acne vulgaris and some pyogenic skin eruptions. 1956-1957 Antibiot Annu pmid:13425373
TIDWELL RA and LEWIS D The use of erythromycin as a prophylactic agent. 1956-1957 Antibiot Annu pmid:13425374
LEVINE ER and FROMAN A The efficacy of erythromycin in respiratory infections. 1956-1957 Antibiot Annu pmid:13425495
CALESNICK B Effectiveness of oral erythromycin propionate in commonly occurring infections. 1959-1960 Antibiot Annu pmid:13806941
LOUGHLIN EH et al. Antibiotic therapy of acute gonococcal infections; a study of the comparative efficacy of triacetyloleandomycin, erythromycin, and penicillin V in the treatment of acute gonococcal urethritis. 1958-1959 Antibiot Annu pmid:13637747
STEPHENS VC and CONINE JW Esters of erythromycin. III. Esters of low molecular weight aliphatic acids. 1958-1959 Antibiot Annu pmid:13637765
MARMELL M et al. Clinical trial of erythromycin propionate for acute anterior gonococcal urethritis. 1959-1960 Antibiot Annu pmid:14421354